Investor Backing & Capital Strength:
The company raised sizable Series A and B rounds totaling well over $100M and was reported at a unicorn valuation, signaling strong investor confidence and runway. Funding momentum closely followed rapid operational scaling across patients and providers.
Profitability:
The company is described as profitable despite rapid expansion, an uncommon outcome among digital health peers. This indicates financial discipline alongside continued investment in growth and product.
Strategic Partnerships:
Extensive in‑network relationships with major commercial, Medicare, and Medicaid plans and collaborations with health systems broaden access and distribution. Most patients are able to pay nothing out of pocket through these arrangements.
